Literature DB >> 22572493

Inferior vena cava obstruction: long-term results of endovascular management.

B C Srinivas1, P V Dattatreya, K H Srinivasa, C N Manjunath.   

Abstract

BACKGROUND: Hepatic venous outflow obstruction (HVOO) can have acute or chronic presentation. In the chronic variety of inferior vena cava (IVC) obstruction, endovascular management with balloon angioplasty and stent implantation has emerged as a feasible, safe alternative to surgery which has high incidence of mortality and morbidity. AIMS AND
OBJECTIVES: To study the feasibility and long-term follow-up of endovascular management of chronic IVC obstruction.
METHODS: We studied 12 cases of HVOO who underwent endovascular management (balloon dilatation ± stenting). In most of the cases, the cause of obstruction was not obvious, but one case had metastatic hepatic nodules compressing on IVC. Diagnosis was established by clinical examination, venous Doppler and was confirmed by venography and/or computed tomography (CT) angiography. Cases underwent balloon dilatation and/or stenting.
RESULTS: Out of 12 cases, six had membranous obstruction (four complete and two incomplete), five cases had segmental stenosis and one case had tumour compression. The lesion was crossed with either guide wire or Brockenbrough needle with Mullins sheath assembly and balloon dilatation was done with Inoue or Mansfield balloon. Seven cases underwent balloon dilatation alone while five cases underwent stenting. There was procedural success in all cases with reduction of gradient by 84%, disappearance of collaterals and clinical improvement. During the follow-up of 13 years, one case had restenosis, which was managed by stenting.
CONCLUSION: Endovascular management of IVC obstruction is safe with good long-term patency rates.
Copyright © 2012 Cardiological Society of India. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22572493      PMCID: PMC3860720          DOI: 10.1016/S0019-4832(12)60054-6

Source DB:  PubMed          Journal:  Indian Heart J        ISSN: 0019-4832


  21 in total

1.  Management of idiopathic obstruction of the hepatic and suprahepatic inferior vena cava with a self-expanding metallic stent.

Authors:  U Kaul; R Agarwal; P Jain; S Sharma; S Sharma; H S Wasir
Journal:  Cathet Cardiovasc Diagn       Date:  1996-11

2.  Dilatation of the inferior vena cava using an expandable metal stent in Budd-Chiari syndrome.

Authors:  A Gillams; R Dick; A Platts; D Irving; K Hobbs
Journal:  J Hepatol       Date:  1991-09       Impact factor: 25.083

Review 3.  Membranous obstruction of the inferior vena cava (obliterative hepatocavopathy, Okuda).

Authors:  K Okuda
Journal:  J Gastroenterol Hepatol       Date:  2001-11       Impact factor: 4.029

4.  Budd-Chiari syndrome: current management options.

Authors:  D P Slakey; A S Klein; A C Venbrux; J L Cameron
Journal:  Ann Surg       Date:  2001-04       Impact factor: 12.969

5.  The Budd-Chiari syndrome. Medical and surgical management of 30 patients.

Authors:  P M McCarthy; J A van Heerden; M A Adson; L W Schafer; R H Wiesner
Journal:  Arch Surg       Date:  1985-06

6.  Management of the Budd-Chiari syndrome by balloon cavoplasty.

Authors:  B K De; P K Biswas; S Sen; D Das; K K De; U Das; S K Mandal; D Majumdar
Journal:  Indian J Gastroenterol       Date:  2001 Jul-Aug

7.  Budd-Chiari syndrome: our experience of 71 patients.

Authors:  V Singh; S K Sinha; C K Nain; P Bambery; U Kaur; S Verma; Y K Chawla; K Singh
Journal:  J Gastroenterol Hepatol       Date:  2000-05       Impact factor: 4.029

8.  Angioplasty for long-term treatment of patients with Budd-Chiari syndrome.

Authors:  L G Martin; J M Henderson; W J Millikan; W J Casarella; S L Kaufman
Journal:  AJR Am J Roentgenol       Date:  1990-05       Impact factor: 3.959

9.  Hepatic inferior vena cava obstruction: treatment of two types with Gianturco expandable metallic stents.

Authors:  S Furui; S Sawada; T Irie; K Makita; T Yamauchi; S Kusano; K Ibukuro; H Nakamura; E Takenaka
Journal:  Radiology       Date:  1990-09       Impact factor: 11.105

10.  Mechanisms of angioplasty in hemodialysis fistula stenoses evaluated by intravascular ultrasound.

Authors:  C J Davidson; G E Newman; K H Sheikh; K Kisslo; R S Stack; S J Schwab
Journal:  Kidney Int       Date:  1991-07       Impact factor: 10.612

View more
  8 in total

1.  An Idiopathic Membranous IVC Obstruction: Presenting as a Variant of the BCS.

Authors:  Amirtha Ganesh B; Ravi Cherian Mathew; Ananathakrishnan N
Journal:  J Clin Diagn Res       Date:  2013-04-01

2.  Endovascular stenting of IVC using Brockenborough's needle in Budd-Chiari syndrome--a case report.

Authors:  Pawan Poddar; Sudarsana Gurizala; Sudarshan Rao
Journal:  Indian Heart J       Date:  2014-04-16

3.  A caval homograft for Budd-Chiari syndrome due to inferior vena cava obstruction.

Authors:  Andrea Mancuso; Luigi Martinelli; Luciano De Carlis; Antonio Gaetano Rampoldi; Giovanni Magenta; Aldo Cannata; Luca Saverio Belli
Journal:  World J Hepatol       Date:  2013-05-27

4.  Timing of Transjugular Intrahepatic Portosystemic Shunt for Budd-Chiari Syndrome: An Italian Hepatologist's Perspective.

Authors:  Andrea Mancuso
Journal:  J Transl Int Med       Date:  2017-12-29

5.  Iliocaval Confluence Stenting for Chronic Venous Obstructions.

Authors:  Rick de Graaf; Mark de Wolf; Anna M Sailer; Jorinde van Laanen; Cees Wittens; Houman Jalaie
Journal:  Cardiovasc Intervent Radiol       Date:  2015-03-14       Impact factor: 2.740

6.  Trapped vessel of abdominal pain with hepatomegaly: A case report.

Authors:  Sirisha Grandhe; Joy A Lee; Ankur Chandra; Christopher Marsh; Catherine T Frenette
Journal:  World J Hepatol       Date:  2018-11-27

7.  Inferior vena cava thrombosis as a possible cause of nephrotic-range proteinuria: two case reports.

Authors:  Yana Apostolova; Patricia Mehier; Salah D Qanadli; Menno Pruijm
Journal:  J Med Case Rep       Date:  2021-11-25

8.  Evaluation of outcome from endovascular therapy for Budd-Chiari syndrome: a systematic review and meta-analysis.

Authors:  Gauri Mukhiya; Xueliang Zhou; Xinwei Han; Dechao Jiao; Gaurab Pokhrel; Yahua Li; Sita Pokhrel
Journal:  Sci Rep       Date:  2022-09-28       Impact factor: 4.996

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.